Ryman (RYM) reported a 1H23 result in-line with our expectations due to strong re-sale gains offset by higher costs and weak new-sale gains; annuity EBITDA was up 35% vs PCP and 14% ahead of our estimates
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.